Miglitol is an alpha-glucosidase inhibitor utilized in the management of type 2 diabetes mellitus to improve glycemic control. By inhibiting the enzymatic breakdown of complex carbohydrates into absorbable… Read more


![Chemical structure of (2S,3R,4R,5S)-3,4,5-Tris(phenylmethoxy)-2-[(phenylmethoxy)methyl]-1-(2-propen-1-yl)-piperidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1203659-55-5-2S3R4R5S-345-Trisphenylmethoxy-2-phenylmethoxymethyl-1-2-propen-1-yl-piperidine.png&w=3840&q=75)
![Chemical structure of (2S,3R,4R,5S)-3,4,5-Tris(phenylmethoxy)-2-[(phenylmethoxy)methyl]-1-piperidineethanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1445783-86-7-2S3R4R5S-345-Trisphenylmethoxy-2-phenylmethoxymethyl-1-piperidineethanol.png&w=3840&q=75)



Miglitol is an alpha-glucosidase inhibitor utilized in the management of type 2 diabetes mellitus to improve glycemic control. By inhibiting the enzymatic breakdown of complex carbohydrates into absorbable monosaccharides, this medication effectively reduces postprandial blood glucose levels. To support the rigorous analytical requirements of pharmaceutical development and manufacturing, this category provides a comprehensive range of high-quality reference materials. These include the active pharmaceutical ingredient (API), along with a diverse selection of pharmacopeial and non-pharmacopeial impurities, such as deoxynojirimycin and various piperidinetriol derivatives. Furthermore, stable isotope labelled compounds, including deuterated forms like Miglitol-d4, are available to serve as internal standards for mass spectrometry-based assays. Chemists and researchers utilize these precise standards for critical impurity profiling, method validation, and ongoing quality control, ensuring accuracy and compliance throughout the pharmaceutical lifecycle.